Vitamin C is Taken Up by Human T Cells Via Sodium-dependent Vitamin C Transporter 2 (SVCT2) and Exerts Inhibitory Effects on the Activation of These Cells in Vitro
Overview
Affiliations
Vitamin C is an essential micronutrient that affects immune responses. T cells are one of the main players in acquired immunity and have been reported to be influenced by in vivo vitamin C supplementation. Yet, the way by which T cells uptake vitamin C and what direct effects vitamin C exerts on the cells are not known. To elucidate, we isolated human peripheral blood T cells and analyzed the expression of sodium-dependent vitamin C transporters (SVCT). T cells were activated in vitro in the absence or presence of vitamin C, before or after activation. As results, human T cells expressed SVCT2, but not SVCT1, and the expression level increased following activation. Vitamin C added in the culture media generally did not affect T-cell behaviors following activation, such as proliferation, apoptosis, expression of CD25 and CD69, and interleukin 2 secretion, regardless whether it was added before or after activation. However, exceptionally, high concentration vitamin C, when it was added before activation, but not after activation, did exert toxic effects on cell activation with respect to the above-mentioned parameters. In conclusion, we showed the expression of SVCT2 in human T cells for the first time. Vitamin C exerted toxic effects, at least in vitro, when the concentration was high and when it was given before activation. These toxic effects are not thought to be via anti-oxidant effects of vitamin C.
Low Levels of Serum and Intracellular Vitamin C in Hospitalized COVID-19 Patients.
Boerenkamp L, Gijsbers B, Ververs E, Pijpers E, Spaetgens B, de Coninck A Nutrients. 2023; 15(16).
PMID: 37630843 PMC: 10458240. DOI: 10.3390/nu15163653.
Differences in the metabolomic profile of the human palatine tonsil between pediatrics and adults.
Lee S, Kim S, Kim S, Oh S, Kong S, Lee H PLoS One. 2023; 18(7):e0288871.
PMID: 37523386 PMC: 10389742. DOI: 10.1371/journal.pone.0288871.
Pharmacological ascorbate as a novel therapeutic strategy to enhance cancer immunotherapy.
Zaher A, Stephens L, Miller A, Hartwig S, Stolwijk J, Petronek M Front Immunol. 2022; 13:989000.
PMID: 36072595 PMC: 9444023. DOI: 10.3389/fimmu.2022.989000.
Firouzi S, Pahlavani N, Gholizadeh Navashenaq J, Clayton Z, Beigmohammadi M, Malekahmadi M Clin Nutr Open Sci. 2022; 44:144-154.
PMID: 35783349 PMC: 9233349. DOI: 10.1016/j.nutos.2022.06.006.
Dey R, Bishayi B Inflammopharmacology. 2022; 30(4):1303-1322.
PMID: 35704229 DOI: 10.1007/s10787-022-01012-z.